Skip to content
healthcare.dev
Get a free key

ESOMEPRAZOLE MAGNESIUM

NDC 69097-527, ESOMEPRAZOLE MAGNESIUM, granule, for suspension, extended release, from Cipla USA Inc..

Product NDC
69097-527
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
GRANULE, FOR SUSPENSION, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211752
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-527 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ESOMEPRAZOLE MAGNESIUM10 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

Package NDCNDC-11Package
69097-527-346909705273430 GRANULE, FOR SUSPENSION, EXTENDED RELEASE in 1 CARTON (69097-527-34)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/180490d1-c165-4bb9-96b1-12e727256e4e

  • NADAC price for package 69097052734

    GET /v1/drugs/nadac/69097052734

Use it

Look up 69097-527 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-527 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-527. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.